Invasive mucinous adenocarcinomas with spatially separate lung lesions: Analysis of clonal relationship by comparative molecular profiling Journal Article


Authors: Yang, S. R.; Chang, J. C.; Leduc, C.; Tan, K. S.; Dogan, S.; Benayed, R.; Borsu, L.; Offin, M.; Drilon, A.; Travis, W. D.; Arcila, M. E.; Ladanyi, M.; Rekhtman, N.
Article Title: Invasive mucinous adenocarcinomas with spatially separate lung lesions: Analysis of clonal relationship by comparative molecular profiling
Abstract: Introduction: Pulmonary invasive mucinous adenocarcinomas (IMAs) often present with spatially separate lung lesions. Clonal relationship between such lesions, particularly those involving contralateral lobes, is not well established. Here, we used comparative genomic profiling to address this question. Methods: Patients with genomic analysis performed on two IMAs located in different lung regions were identified. Molecular assays included DNA-based next-generation sequencing (NGS) for 410 to 468 genes (Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets), RNA-based NGS for 62 genes (Memorial Sloan Kettering-Fusion), or non-NGS assays. Results: Comparative genomic profiling was performed on two separate IMAs in 24 patients, of whom 19 had contralateral lesions. Tumors from all but one patient shared matching driver alterations, including KRAS (n = 19), NRG1 (n = 2), ERBB2 (n = 1) or BRAF (n = 1). In addition, in patients with paired tumors profiled by NGS (n = 12), shared driver alterations were accompanied by up to 4 (average 2.6) other identical mutations, further supporting the clonal relationship between the tumors. Only in a single patient separate IMAs harbored entirely nonoverlapping mutation profiles, supporting clonally unrelated, distinct primary tumors. Notably, in a subset of patients (n = 3), molecular testing confirmed a clonal relationship between the original resected IMAs and subsequent contralateral IMA presenting after an extremely long latency (8.1–11.7 y). Conclusions: Comparative molecular profiling supports that nearly all separate pulmonary IMA lesions represent intrapulmonary spread arising from a single tumor and documents a subset with a remarkably protracted course of intrapulmonary progression. This study reinforces the unique biology and clinical behavior of IMAs while further highlighting the value of genomic testing for clarifying the clonal relationship between multiple lung carcinomas. © 2021 International Association for the Study of Lung Cancer
Keywords: lung; kras; nsclc; molecular diagnostics; invasive mucinous adenocarcinoma; comparative molecular profiling
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 7
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-07-01
Start Page: 1188
End Page: 1199
Language: English
DOI: 10.1016/j.jtho.2021.03.023
PUBMED: 33839364
PROVIDER: scopus
PMCID: PMC8240964
DOI/URL:
Notes: Article -- Export Date: 2 August 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Natasha Rekhtman
    425 Rekhtman
  2. Marc Ladanyi
    1328 Ladanyi
  3. William D Travis
    743 Travis
  4. Snjezana Dogan
    187 Dogan
  5. Maria Eugenia Arcila
    657 Arcila
  6. Alexander Edward Drilon
    633 Drilon
  7. Rym Benayed
    188 Benayed
  8. Jason Chih-Peng Chang
    134 Chang
  9. Kay See   Tan
    241 Tan
  10. Michael David Offin
    170 Offin
  11. Soo Ryum Yang
    76 Yang